Adverse Event Management
FDA Approves Ruxolitinib for GVHD Treatment
BY BRIELLE BENYON
Nurses Can Help With CIPN's Effects on Daily Living
BY BRIELLE BENYON
Opioid-Induced Nausea and Vomiting: What the Oncology Nurse Should Know
BY JEANNETTE (JEANNIE) MEYER, MSN, RN, CCRN-K, CCNS, PCCN-K, ACHPN; DANIEL KARLIN, MD; AND CHRISTOPHER PIETRAS, MD
ONN's Top 5 Stories: April 2019
BY JESSICA SKARZYNSKI
Preventing Radiation Dermatitis
BY RAYMOND CHAN, PHD, RN, BN, MAPPSC
Patients and Caregivers Withhold Cancer-Related Information
BY BRIELLE BENYON
Oral Ice Pack Soothes Mouth Sores From Chemotherapy
BY KRISTIE L. KAHL
Special Assessments Are Needed When Treating Older Adults With Cancer
BY BETH FAND INCOLLINGO
Understanding the Management of Chronic AEs After Radiation Therapy
BY KRISTIE L. KAHL
External Resources
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright OncNursing 2006-2018
Intellisphere, LLC. All Rights Reserved.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright OncNursing 2006-2018
Intellisphere, LLC. All Rights Reserved.